ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MTFB Motif Bio Plc

0.50
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.50 0.40 0.55 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Motif Bio Share Discussion Threads

Showing 9276 to 9299 of 9925 messages
Chat Pages: Latest  373  372  371  370  369  368  367  366  365  364  363  362  Older
DateSubjectAuthorDiscuss
16/4/2021
15:12
If this relists at 5p - if, and it’s a very big if - I will donate a four figure sum to a charity of my choosing.

Sadly that charity won’t probably get this promise as the cHarities of Gold and Lumsden have snaffled the loot

scottdavid70
16/4/2021
14:44
What will you do if this goes to 50p on RTO Scott. Cleft stick or what? Celebrate you have your cash back or despondency that you were wrong. I think the latter might be more important to you - in which case the stock market might not be your safe place.
small crow
16/4/2021
14:38
Anyone else blown away with the ‘marketingR17; for the new RTO company and the ‘advertising’ for Iclaprim to sell it?

Personally this flurry of activity is bewildering - the vastness of the content is inspiring- there I was thinking these guys were hopeless and clown like and extremely greedy for themselves but the widespread outreach of the publicity is breathtaking

scottdavid70
16/4/2021
08:15
First question in the audit probably went like this -

“So what have you two clowns done to earn close to several million dollars between you in the past 2 years and Graham I see you are due a bonus for the RTO that you caused due to your failure to get Iclaprim approved? Do you think that is looking after shareholders rights?”

“We see you did not complete a Corporate Governance report at the end of 2019, in fact you actively didn’t fill one in, but are suggesting you would like to do it after a RTO to paint the picture clearly very differently than the one shareholders have had to endure with your two steering this rudderless shipwreck? You don’t need to answer we can see why you didn’t fill
In a Corporate Governance report and it doesn’t look good for you both for future employment.”

scottdavid70
16/4/2021
08:08
Bet some on LSE looked in for a RNS at 7am - they have no idea at all over there how little this company cares about them or is ever on time with anything. There was more chance of Graham Lumsden giving back his unearned salary and bonus than a RNS today or in the next two weeks.

Scrambling around in the ether of failure is what this shower is proficient at

scottdavid70
15/4/2021
20:46
For Robblertwo on LSE as most of the moronic folk seem to be on there and don’t read RNS’s even thought hey have their money tied up here which astounds me - 27th January 2021

“ In order to convene the General Meeting, the Company is required to publish an AIM Admission Document which details, inter alia, the terms of the Proposed Transaction. As per the HOT, consideration for the Proposed Transaction will be paid in ordinary shares of Motif. In addition to the Fundraising, it is intended that the Company will carry out an appropriate share consolidation and that Motif will change its name.”

Got it Robbler?

scottdavid70
15/4/2021
15:17
The quality of investors on LSEis jarring

Still asking if a vote is needed to approve the RTO

No one wonder Directors as useless as GRAHAM LUMSDEN get away with what they do - investors are as clueless as them

scottdavid70
15/4/2021
09:40
Remember this from the 27th January 2021


Jonathan Gold, Motif's President and Chief Business Officer, commented: "The Motif Directors are encouraged by the way the Proposed Transaction is progressing and I look forward to providing our shareholders with further updates and additional information regarding the Target in due course."

Not really surprised as we are still awaiting a Lamellar/Iclaprim update from
May 2019...

Clowns

scottdavid70
15/4/2021
08:47
Mid April and as we expected - those who have been through the delays for the FDA submission at MOTIF BIO - the information surrounding Iclaprim etc - there is nothing. Two more weeks of hiding for GRAHAM LUMSDEN of BIOMARCK and JONATHAN GOLD and then the curtain of failure is pulled back for the very last time

The only ‘marketingR17; that will be done this next few weeks is this shower looking for new jobs

scottdavid70
14/4/2021
13:58
How could we forget?
small crow
14/4/2021
12:39
Don’t forget these men GRAHAM LUMSDEN and JONATHAN GOLF haven’t mentioned ICLAPRIM once in the sense of trying to advertise its value to be able to SELL it ONCE in almost 2 years....NOT ONCE

strange that isn’t? If you are trying to
Seek an asset like like your car or house to be you not put it on every website you can and promote it’s virtues constantly? Wonder why they haven’t mentioned it could it be they are somehow going to benefit now in the ORANGE AVENUE TECHNOLOGIES LLC 10% commission transaction?

#MotifBio
#SPAngel
#WalbrookPR

scottdavid70
14/4/2021
11:51
Oh anyone who has followed the BOD of MOTIF BIO complete disdain for shareholders and deadlines know that there will be nothing till May

LUMSDEN was a ghost after the FDA deyapart from telling investors there was no indication of new clinical trials in the CRL - that was a goodie from our GRAHAM. Just the full phase iii in the end wasn’t Lummy Bear?

scottdavid70
14/4/2021
11:49
Anyone else notice how there was no mention of ‘marketingR17; up until the last RNs?

Previous ones just mentioned the AIM admission document- making investors think funding wasn’t an issue.

However, suddenly ’marketingR17; is now needed before we get the AIM admission document- makes you wonder if these guys know what they are doing - GRAHAM LUMSDEN and JONATHAN GOLD that is.

We have been paying them MILLIONS OF DOLLARS but apparently they don’t know the basics of a RTO and let on in the game suddenly need ‘marketingR17;

Hard to watch this car crash for so
Long unfolding

scottdavid70
14/4/2021
09:33
Cash cows love new pastures and there are none greedier than these cash cows
scottdavid70
13/4/2021
20:29
So he's moved on to pastures new seems the rto was a lot of waffle then
tnt99
13/4/2021
12:09
Honestly JONATHAN GOLD and GRAHAM LUMSDEN creaking MILLIONS OF DOLLARS in salaries that have produced ZERO value for INVESTORS doesn’t bother me at all

JOHN PALMER of ORANGE AVENUE TECHNOLOGIES LLC making 10% COMMISSION for ICLAPRIM when he COULDNT SELL it for almost 2 years doesn’t bother me at

MOTIF BIO DIRECTORS are role models for all companies

BIOMARCK are lucky to get GRAHAM LUMSDEN as their PRESIDENT and CEO

scottdavid70
13/4/2021
10:52
It may be frustrating but don't let it get under your skin Scott.
small crow
13/4/2021
08:41
So MILLIONS OF DOLLARS spent on TWO men GRAHAM LUMSDEN who is now PRESIDENT and CEO of BIOMARCK (don’t tell them this story especially the shareholders) and JONATHAN GOLD but ZERO RETURN for SHAREHOLDERS

DO NOT ASK ANY QUESTIONS- LETS KEEP IT JUST BETWEEN US

scottdavid70
13/4/2021
08:39
Also while we are on the done low and definitely don’t repeat this but GRAHAM LUMSDEN and JONATHAN GOLD have syphoned MILLIONS of US DOLLARS to their bank accounts but have FAILED to get ICLAPRIM approved or SOLD

JOHN PAlMER OF ORANGE AVENUE TECHNOLOGIES LLC has a 10% commission on the SALE of ICLAPRIM but couldn’t SELL it on a salary. Strange but DEFINITELY DONT ASK ANY QUESTIONS OF THE BOD OR WALBROOK PR OR share price ANGEL

scottdavid70
13/4/2021
08:35
Don’t shout it loudly as we must keep it hush hush everyone but the drug ICLAPRIM that GRAHAM LUMSDEN and JONATHAN GOLD and JOHN PALMER failed to get approved or sell has had zero and I mean ZERO PUBLICITY OR ADVERTISING in nearly TWO YEARS.

This drug that well over a $100 million dollars has been spent on is apparently DEAD.

There is a company called ORANGE AVENUE TECHNOLOGIES LLC that apparently EXISTS but NO ONE can FIND

DONT ASK ANY QUESTIONS OF THE BOARD OR THE RELATED COMPANIES LIKE share price ANGEL AND WALBROOK PR WHATEVER YOU DO WHATS GOING ON

scottdavid70
13/4/2021
08:11
Little chance? Bob Hope has much more trust me

Dork forgot the all new super important important‘marketing’ starts in 3 days


Haha these clowns running the clock down only

scottdavid70
12/4/2021
19:23
If it don't happen this week then I'm starting to think we have little chance of any return on our investment in intclam bit sad as probably will be needed in the future
tnt99
12/4/2021
15:11
Another day another impossible search for Orange Avenue Technologies LLC.

Where for art thou Orange and Mr Palmer?

Do we think the new company Motif Bio “cough” “cough” is RTOing into is happy that part of the deal is with a company that basically doesn’t exist?

Should make for good reading in the AIM
Admission Document

scottdavid70
11/4/2021
10:24
Last few weeks for this shower before they rinse and repeat at various companies like Biomarck and Orange Avenue Technologies LLC
scottdavid70
Chat Pages: Latest  373  372  371  370  369  368  367  366  365  364  363  362  Older

Your Recent History

Delayed Upgrade Clock